381 related articles for article (PubMed ID: 16788794)
1. [Legal (liability) aspects of PSA determination].
Mielke K
Urologe A; 2006 Jun; 45(6):756-65. PubMed ID: 16788794
[No Abstract] [Full Text] [Related]
2. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
[No Abstract] [Full Text] [Related]
3. PSA screening: the bottom line.
Elhilali MM
CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
[No Abstract] [Full Text] [Related]
4. [Large part of Swedish men PSA tested for early prostatic cancer. Few aware of the disadvantages of the test].
Bratt O; Grenabo L
Lakartidningen; 2010 Feb 17-23; 107(7):432-5. PubMed ID: 20384075
[No Abstract] [Full Text] [Related]
5. [The PSA test does not hold for screening. Good--but not good enough].
Holmström B; Johansson M; Bratt O; Stattin P
Lakartidningen; 2010 Feb 17-23; 107(7):436, 438-9. PubMed ID: 20384076
[No Abstract] [Full Text] [Related]
6. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
Ito K
Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
[No Abstract] [Full Text] [Related]
7. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
[No Abstract] [Full Text] [Related]
8. How valuable is prostate-specific antigen screening?
Handler S
Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
[No Abstract] [Full Text] [Related]
9. [Comments on the PSA in primary health care: survey results in more "losers" than "winners"].
Bratt O
Lakartidningen; 2003 Nov; 100(48):4014-5. PubMed ID: 14717100
[No Abstract] [Full Text] [Related]
10. PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence.
Perrin P
Eur Urol; 2006 Mar; 49(3):418-9. PubMed ID: 16459016
[No Abstract] [Full Text] [Related]
11. Is an improved PSA screening test in sight?
Savage L
J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
[No Abstract] [Full Text] [Related]
12. Why PSA testing does have value.
Kirby M
Practitioner; 1997 Jul; 241(1576):363. PubMed ID: 9425708
[No Abstract] [Full Text] [Related]
13. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
14. Prostate cancer detection: beware of the low PSA.
Haas GP
Can J Urol; 2007 Jun; 14(3):3534. PubMed ID: 17594742
[No Abstract] [Full Text] [Related]
15. [Elevated PSA--what to do?].
Machemer H; Rohde D
MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
[No Abstract] [Full Text] [Related]
16. The cautionary tale of PSA testing.
Hoffman RM; Zeliadt SB
Arch Intern Med; 2010 Jul; 170(14):1262-3. PubMed ID: 20660847
[No Abstract] [Full Text] [Related]
17. PSA and prostate cancer screening: the challenge of the new millennium.
Bjartell A
Eur Urol; 2007 Nov; 52(5):1284-6. PubMed ID: 17720305
[No Abstract] [Full Text] [Related]
18. Efficacy vs effectiveness in prostate-specific antigen screening.
Albertsen PC
J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
[No Abstract] [Full Text] [Related]
19. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Rosser CJ; Parker A
J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
[No Abstract] [Full Text] [Related]
20. PSA level changes over time in men with an initial PSA level of < or = 4 ng/ml.
Bangma C
Nat Clin Pract Urol; 2006 Oct; 3(10):520-1. PubMed ID: 17031372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
